FI54120C - Foerfarande foer framstaellning av farmaceutiskt anvaendbara antidepressivt verkande tetrahydropyrimido(1,2-a)indol-tetrahydro-1,3-diazepino(1-2-a)indol- och dihydroimidazo(1,2-a)indolderivat - Google Patents

Foerfarande foer framstaellning av farmaceutiskt anvaendbara antidepressivt verkande tetrahydropyrimido(1,2-a)indol-tetrahydro-1,3-diazepino(1-2-a)indol- och dihydroimidazo(1,2-a)indolderivat

Info

Publication number
FI54120C
FI54120C FI45/72A FI4572A FI54120C FI 54120 C FI54120 C FI 54120C FI 45/72 A FI45/72 A FI 45/72A FI 4572 A FI4572 A FI 4572A FI 54120 C FI54120 C FI 54120C
Authority
FI
Finland
Prior art keywords
indol
dihydroimidaso
anvaidbara
antidepressivt
verkande
Prior art date
Application number
FI45/72A
Other languages
English (en)
Finnish (fi)
Other versions
FI54120B (fi
Inventor
Alan Chapman White
Robin Michael Black
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Application granted granted Critical
Publication of FI54120B publication Critical patent/FI54120B/fi
Publication of FI54120C publication Critical patent/FI54120C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
FI45/72A 1971-01-11 1972-01-10 Foerfarande foer framstaellning av farmaceutiskt anvaendbara antidepressivt verkande tetrahydropyrimido(1,2-a)indol-tetrahydro-1,3-diazepino(1-2-a)indol- och dihydroimidazo(1,2-a)indolderivat FI54120C (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB125071*[A GB1366133A (en) 1971-01-11 1971-01-11 Fused ring indole derivatives
GB4095971 1971-09-02
GB5646771 1971-12-06

Publications (2)

Publication Number Publication Date
FI54120B FI54120B (fi) 1978-06-30
FI54120C true FI54120C (fi) 1978-10-10

Family

ID=27253859

Family Applications (1)

Application Number Title Priority Date Filing Date
FI45/72A FI54120C (fi) 1971-01-11 1972-01-10 Foerfarande foer framstaellning av farmaceutiskt anvaendbara antidepressivt verkande tetrahydropyrimido(1,2-a)indol-tetrahydro-1,3-diazepino(1-2-a)indol- och dihydroimidazo(1,2-a)indolderivat

Country Status (20)

Country Link
JP (1) JPS5531156B2 (sv)
AR (1) AR192734A1 (sv)
AT (1) AT312595B (sv)
AU (1) AU464388B2 (sv)
BE (1) BE777911A (sv)
CA (1) CA1012150A (sv)
CH (1) CH573938A5 (sv)
CY (1) CY926A (sv)
DK (1) DK150143C (sv)
EG (1) EG10888A (sv)
ES (2) ES398678A1 (sv)
FI (1) FI54120C (sv)
FR (1) FR2121699B1 (sv)
GB (1) GB1366133A (sv)
HK (1) HK52877A (sv)
IE (1) IE35956B1 (sv)
KE (1) KE2777A (sv)
MY (1) MY7800048A (sv)
NL (1) NL174251C (sv)
SE (1) SE398645B (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1520611A (en) * 1976-06-11 1978-08-09 Wyeth John & Brother Ltd Fused ring indole derivatives
JPS5845741B2 (ja) * 1977-06-06 1983-10-12 株式会社日立製作所 情報検索装置
ZA824382B (en) * 1981-07-07 1984-02-29 Wyeth John & Brother Ltd Anti-obesity agents
JPS60204057A (ja) * 1984-03-28 1985-10-15 Casio Comput Co Ltd デ−タ記憶機能付小型電子機器
GB8606253D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Pyrimidoindoles
GB8606254D0 (en) * 1986-03-13 1986-04-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
GB8614246D0 (en) * 1986-06-11 1986-07-16 Wyeth John & Brother Ltd Substituted pyrimidoindoles
WO2010090680A1 (en) * 2008-12-15 2010-08-12 Wyeth Llc Substituted oxindole cb2 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives
US3586693A (en) * 1969-07-07 1971-06-22 American Home Prod Imidazo(1,2-a)indolin-9-ols

Also Published As

Publication number Publication date
CA1012150A (en) 1977-06-14
NL174251C (nl) 1984-05-16
CH573938A5 (sv) 1976-03-31
SE398645B (sv) 1978-01-09
ES409296A1 (es) 1976-03-16
GB1366133A (en) 1974-09-11
MY7800048A (en) 1978-12-31
DK150143C (da) 1987-06-01
AU3755872A (en) 1973-07-05
BE777911A (fr) 1972-07-11
DK150143B (da) 1986-12-15
NL7200415A (sv) 1972-07-13
KE2777A (en) 1977-10-21
NL174251B (nl) 1983-12-16
EG10888A (en) 1978-06-30
AR192734A1 (es) 1973-03-14
JPS5531156B2 (sv) 1980-08-15
IE35956B1 (en) 1976-07-07
AT312595B (de) 1974-01-10
FR2121699A1 (sv) 1972-08-25
JPS4839500A (sv) 1973-06-09
FR2121699B1 (sv) 1975-08-01
AU464388B2 (en) 1975-08-28
ES398678A1 (es) 1975-05-16
CY926A (en) 1977-12-23
IE35956L (en) 1972-07-11
HK52877A (en) 1977-10-20
FI54120B (fi) 1978-06-30

Similar Documents

Publication Publication Date Title
CA1025866A (en) Cyclic diamine derivatives
SE402592B (sv) Forfarande for framstellning av 2-alkyl-3-acyl-pyrazolo(1,5-a)pyridiner
IL39988A0 (en) Pyrazolopyrimidines and pharmaceutical compositions containing them
CA952259A (en) Foldable bed structure
ZA721805B (en) Platform structure
SE389499B (sv) Analogiforfarande for framstellning av triazolo(4,3-a)(1,4)bensodiazepin-derivat
FI54121C (fi) Foerfarande foer framstaellning av blodtryckssaenkande imidazo-(1,2-a)-imidazoler -pyrimidiner och diazepiner och deras syraadditionssalter
SE396388B (sv) Analogiforfrande for framstellning av 2,3-dihydro-oxo-imidazo-/1,2-a/pyrimidiner
FI54120C (fi) Foerfarande foer framstaellning av farmaceutiskt anvaendbara antidepressivt verkande tetrahydropyrimido(1,2-a)indol-tetrahydro-1,3-diazepino(1-2-a)indol- och dihydroimidazo(1,2-a)indolderivat
CA945529A (en) Foldable ladder
FI54310B (fi) Foerfarande foer framstaellning av nya saosom laekemedel anvaendbara 6-fenyl-4h-s-triazolo(1,5-a)(1,4)bensodiazepin-2-karboxamider
FI55660B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara pyrazolo(3,4-b)pyridinderivat
CA940134A (en) Imidazo (1,2-a) benzimidazole derivatives and process for the preparation thereof
SE380804B (sv) Anologiforfarande for framstellning av s-triazolo (1,5-a) (1,4)
SE399709B (sv) Sett att framstella pyrimido(1,2-a)(1,4)bensodiazepiner
CA970373A (en) Pyrazolo (3,4-b) pyridine-5-carboxamides
SE398122B (sv) Analogiforfarande for framstellning av pyrazino/1,2-a/indol-2-karboxamidiner
IL38215A0 (en) Pyrazolopyrimidines,their preparation and pharmaceutical compositions containing them
CA963464A (en) 4-styrylphenyl-triazole (4,5-d) pyrimidin-7-ol compounds
SE405249B (sv) Forfarande for framstellning av imidazo(2,1-a)isoindoler
AU4579072A (en) Pyrimidopyrimidine derivatives
AU464547B2 (en) Platform structure
CA925510A (en) (pyrazolo(3,4-b)pyridin-5-yl-formamidoethyl) phenylsulfonylureas
CA888729A (en) 4h-pyrido (1,2-a)pyrimidin-4-ones
SE385894B (sv) Forfarande for framstellning av pyrazolo(1,2-b)ftalazindioner